Amsterdam-listed Odyssey has agreed to buy BenevolentAI in a deal valuing the British-based pharmaceuticals firm at up to 1.5 billion euros (US$1.7 billion) after the transaction, the biggest acquisition by a European special purpose acquisition vehicle to date, Reuters reports. Read more.
Related Posts
Startups Axios and the Athletic Discuss Merger, Consider SPAC Deal: WSJ
The discussions are reportedly part of a plan to build a larger online-publishing company that could include going public through a blank-check firm.
Opes Revises Proxy on BurgerFi Deal
The SPAC said it still expects a shareholder vote by year's end on the $100 milion deal.
Houston Natural Resources to Acquire Cunningham Energy Interests
Under the Letter of Intent additional future development funding for up to $600 million from SPAC and PIPE follow-on transactions are also planned.
Tuscan Holdings Shareholders Approve $3B Microvast Deal
The transaction is expected to provide $822 million of gross proceeds to Microvast.